AZLI
Showing 1 - 24 of 24
Ventilator Associated Pneumonia, Prevention, Respiratory Infection Other Trial in Tarragona (Aztreonam lysine, Aerogen Solo,
Terminated
- Ventilator Associated Pneumonia
- +2 more
- Aztreonam lysine
- +2 more
-
Tarragona, SpainCritical Care Department - Hospital Universitario de Tarragona J
Jun 29, 2021
Cystic Fibrosis, Infection, Pseudomonas Trial in Liverpool (Aztreonam, Standard Care)
Completed
- Cystic Fibrosis
- +2 more
- Aztreonam
- Standard Care
-
Liverpool, United KingdomLiverpool Heart & Chest Hospital NHS Trust
Oct 3, 2019
Tracheostomy Infection Trial in Oakland (Inhaled Aztreonam)
Terminated
- Tracheostomy Infection
- Inhaled Aztreonam
-
Oakland, CaliforniaBenioff Children's Hospital Oakland
Jul 9, 2021
Physical Fitness and Technical Skills Trial in Quetta (Plyometric Exercises, Conventional Exercises)
Completed
- Physical Fitness and Technical Skills
- Plyometric Exercises
- Conventional Exercises
-
Quetta, Balochistan, PakistanRehabilitation Department, Sheikh Muhammad bin Zayyed Al-Nahyan
Jul 18, 2023
Complication of Transplanted Lung Trial in Los Angeles, Durham (Aztreonam Lysine for Inhalation (AZLI), Status Post Lung
Completed
- Complication of Transplanted Lung
- Aztreonam Lysine for Inhalation (AZLI)
- Status Post Lung Transplant
-
Los Angeles, California
- +1 more
Dec 22, 2015
Nasopharyngeal Carcinoma Trial in Guangzhou (Recombinant Human Endostatin Injection (Endostar), Fluorouracil (5-Fu), Nedaplatin)
Unknown status
- Nasopharyngeal Carcinoma
- Recombinant Human Endostatin Injection (Endostar)
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer
Dec 20, 2017
Breast Cancer Trial in Hangzhou (Docetaxel)
Unknown status
- Breast Cancer
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
May 7, 2017
Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx
Terminated
- Nasopharynx Cancer
-
Jacksonville, FloridaUniversity of Florida Proton Therapy Institute
Feb 9, 2017
Cystic Fibrosis, Pseudomonas Aeruginosa Trial in Worldwide (AZLI)
Completed
- Cystic Fibrosis
- Pseudomonas Aeruginosa
- AZLI
-
Aurora, Colorado
- +28 more
May 12, 2014
Cystic Fibrosis Trial in Worldwide (Aztreonam for Inhalation Solution (AZLI))
Completed
- Cystic Fibrosis
- Aztreonam for Inhalation Solution (AZLI)
-
Phoenix, Arizona
- +57 more
Jul 7, 2014
Cystic Fibrosis, Burkholderia Infections Trial in Canada, United States (AZLI, Placebo)
Completed
- Cystic Fibrosis
- Burkholderia Infections
- AZLI
- Placebo
-
Mobile, Alabama
- +34 more
Feb 7, 2014
Cystic Fibrosis Trial in United States (FTI, AZLI, Placebo, AZLI)
Completed
- Cystic Fibrosis
- FTI, AZLI
- Placebo, AZLI
-
Anchorage, Alaska
- +35 more
Dec 3, 2013
Cystic Fibrosis, Pseudomonas Aeruginosa Trial in Canada (Aztreonam lysine)
Approved for marketing
- Cystic Fibrosis
- Pseudomonas Aeruginosa
- Aztreonam lysine
-
Calgary, Alberta, Canada
- +3 more
Dec 12, 2012
Cystic Fibrosis Trial in Worldwide (Aztreonam for Inhalation Solution (AZLI), Tobramycin Inhalation Solution (TIS))
Completed
- Cystic Fibrosis
- Aztreonam for Inhalation Solution (AZLI)
- Tobramycin Inhalation Solution (TIS)
-
Anchorage, Alaska
- +91 more
Jun 7, 2011
Cystic Fibrosis Trial in Worldwide (AZLI 75 mg two times a day (BID)/ three times a day (TID))
Completed
- Cystic Fibrosis
- AZLI 75 mg two times a day (BID)/ three times a day (TID)
-
Birmingham, Alabama
- +64 more
May 17, 2011
Cystic Fibrosis Trial in Worldwide (AZLI 75 mg three times a day (TID), Placebo three times a day (TID))
Completed
- Cystic Fibrosis
- AZLI 75 mg three times a day (TID)
- Placebo three times a day (TID)
-
Birmingham, Alabama
- +52 more
Mar 21, 2011
Tobramycin Solution for Inhalation Versus Aztreonam Lysine for
Completed
- Cystic Fibrosis
- Tobramycin solution for inhalation
- Aztreonam lysine for inhalation
- (no location specified)
Oct 26, 2011
Cystic Fibrosis Trial in United States (AZLI 75 mg two times a day (BID)/three times a day (TID), Placebo two times a day
Completed
- Cystic Fibrosis
- AZLI 75 mg two times a day (BID)/three times a day (TID)
- Placebo two times a day (BID)/three times a day (TID)
-
Phoenix, Arizona
- +55 more
Feb 16, 2011
Cystic Fibrosis, Lung Infection, Pseudomonas Aeruginosa Trial in Australia, Canada, United States (AZLI 75 mg three times daily
Completed
- Cystic Fibrosis
- +2 more
- AZLI 75 mg three times daily (TID)
- Placebo three times daily (TID)
-
Phoenix, Arizona
- +39 more
Nov 19, 2010
Cystic Fibrosis, Pseudomonas Aeruginosa Airway Infection Trial in Puerto Rico, United States (Aztreonam Lysine for Inhalation)
Approved for marketing
- Cystic Fibrosis
- Pseudomonas Aeruginosa Airway Infection
- Aztreonam Lysine for Inhalation
-
Birmingham, Alabama
- +64 more
Jul 29, 2011